Inhibition of the pancreatic microsome enzyme release phenomenon by inhibitors of signal peptidase activity.
D000681:Amylases / Q000378:metabolism*; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001550:Benzamidines / Q000494:pharmacology; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D008297:Male; D008861:Microsomes / Q000187:drug effects / Q000201:enzymology*; D010179:Pancreas / Q000201:enzymology*; D010618:Phenanthrolines / Q000494:pharmacology; D010664:Phenylmethylsulfonyl Fluoride / Q000494:pharmacology; D011343:Procaine / Q000494:pharmacology; D051381:Rats; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology; D014108:Tosylphenylalanyl Chloromethyl Ketone / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology*; D000516:alpha-Amylases / Q000378:metabolism*
D001550:Benzamidines; D010618:Phenanthrolines; D014361:Trypsin Inhibitors; D014107:Tosyllysine Chloromethyl Ketone; D014108:Tosylphenylalanyl Chloromethyl Ketone; D011343:Procaine; D010664:Phenylmethylsulfonyl Fluoride; D007611:Aprotinin; D000681:Amylases; D000516:alpha-Amylases; D002918:Chymotrypsin